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ABSTRACT
Objectives: To estimate the prevalence and factors
associated with smoking and misclassification in
pregnant women from INMA (INfancia y Medio
Ambiente, Environment and Childhood) project, Spain,
and to assess the optimal cut-offs for urinary cotinine
(UC) that best distinguish daily and occasional smokers
with varying levels of second-hand smoke (SHS)
exposure.
Design:We used logistic regression models to study the
relationship between sociodemographic variables and
self-reported smoking and misclassification (self-
reported non-smokers with UC >50 ng/ml). Receiver
operating characteristic (ROC) curves were used to
calculate the optimal cut-off point for discriminating
smokers. The cut-offs were also calculated after
stratification among non-smokers by the number of
sources of SHS exposure. The cut-off points used to
discriminate smoking status were the level of UC given by
Youden’s index and for 50 and 100 ng/ml for daily
smokers, or 25 and 50 ng/ml for occasional smokers.
Participants: At the third trimester of pregnancy, 2263
pregnant women of the INMA Project were interviewed
between 2004 and 2008 and a urine sample was collected.
Results: Prevalence of self-reported smokers at the third
trimester of pregnancy was 18.5%, and another 3.9%
misreported their smoking status. Variables associated
with self-reported smoking and misreporting were
similar, including born in Europe, educational level and
exposure to SHS. The optimal cut-off was 82 ng/ml
(95% CI 42 to 133), sensitivity 95.2% and specificity
96.6%. The area under the ROC curve was 0.986 (95%
CI 0.982 to 0.990). The cut-offs varied according to the
SHS exposure level being 42 (95% CI 27 to 57), 82
(95% CI 46 to 136) and 106 ng/ml (95% CI 58 to 227)
for not being SHS exposed, exposed to one, and to two
or more sources of SHS, respectively. The optimal cut-off
for discriminating occasional smokers from non-smokers
was 27 ng/ml (95% CI 11 to 43).
Conclusions: Prevalence of smoking during pregnancy
in Spain remains high. UC is a reliable biomarker for
classifying pregnant women according to their smoking




▪ There is no current consensus regarding the
cut-off point for urinary cotinine in pregnant
women able to discriminate regular or occasional
smokers from non-smokers.
▪ These cut-offs would also differ according to
baseline exposure to second-hand smoke (SHS).
▪ This study assesses the maternal factors influen-
cing both self-reported and misclassification of
smoking and evaluate the optimal cut-off point for
urinary cotinine that best distinguishes smokers
from non-smokers, according to the frequency of
smoking and SHS exposure.
Key messages
▪ The prevalence of both smoking (18.5%) and
SHS exposure (45.9%) was high in a population-
based sample of pregnant women in Spain.
▪ Factors associated with self-reported smoking
and misreporting were similar, including lower
level of education and living in a smoking envir-
onment, which highlights the need of reinforcing
the preventive interventions and policies.
▪ The optimal cut-off point to discriminate smokers
from non-smokers varied according to the fre-
quency of smoking (occasional or daily smokers)
and SHS exposure levels.
▪ This study highlights the importance of SHS
exposure for selecting reference cut-offs to dis-
criminate smoking status, especially in high-SHS-
exposed populations.
Strengths and limitations of this study
▪ This study has the ability to assess the role of
baseline exposures to SHS in the estimate of
cut-offs, given the detailed information collected
on SHS exposure and its elevated prevalence.
▪ This study uses population-based samples of
pregnant women from the INfancia y Medio
Ambiente birth cohort, which might not be fully
representative of all pregnant women in the study
areas.
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INTRODUCTION
Risks for mother and fetus have been widely related to
smoking during pregnancy.1 Several studies have indi-
cated that pregnant women tend to under-report their
consumption of tobacco,2–8 owing to social pressure9 or
to avoid criticism from health professionals.3 Indeed, it
is known to be a higher rate of misreporting of smoking
among the groups in which it is not considered as
acceptable, such as pregnant women and patients with
smoking-related diseases.9
Cotinine is the main metabolite of nicotine and the
biomarker of choice for distinguishing smokers from
non-smokers and for assessing exposure to second-hand
smoke (SHS).10 Women’s clearance of cotinine is faster
during pregnancy11 and their plasma half-life is a little
less than 9 h.12 For this reason, urinary cotinine (UC)
tests may give false negatives in pregnant women who
have not recently smoked.
There is no current consensus regarding the cut-off
point for UC in pregnant women. Several thresholds
have been proposed, with 50 ng/ml being the most
widely used.13–16 On the other hand, Higgins et al17 pro-
posed 25 ng/ml as the cut-off point, while Gorber et al9
underlined the need to decide on a suitable threshold
for pregnant women in particular, for whom the sensitiv-
ity of the test may be different, and also suggested that a
new cut-off point should be established for occasional
smokers. Spierto et al18 found 79 ng/ml as the cut-off
between non-smoking and smoking pregnant women.
The aims of our study were (1) to assess the preva-
lence of self-reported smoking and the UC levels in a
cohort of pregnant women; (2) to assess the prevalence
of misclassiﬁcation of maternal smoking status according
to the most widely accepted cut-off point in the litera-
ture of 50 ng/ml, and to study maternal factors asso-
ciated with both self-reported and misclassiﬁcation of
maternal smoking and (3) to identify the optimal cut-off
point for UC that best distinguishes smokers from non-
smokers in our study sample, according to the frequency




The INMA (INfancia y Medio Ambiente, Environment and
Childhood) project is a Spanish multicentre prospective
birth cohort study which aims to evaluate the impact of
exposure to the most prevalent environmental pollutants,
and the role of diet on fetal and infant growth, health and
development.19 From eligible pregnant women recruited
between 2003 and 2008, 56% agreed to participate. The
inclusion criteria were at least 16 years of age, singleton
pregnancy, enrolment at 10–13 weeks of gestation, no
assisted conception, delivery scheduled at the reference
hospital and no communication handicap. There was no
upper age limit for becoming a member of the cohort. Of
the 2644 women who agreed to participate in the study,
119 (4.5%) were lost (59 miscarriages, 8 fetal death, 47
withdrew and 5 lost to follow-up). Around week 32 of their
pregnancy, 2263 of the 2525 remaining women com-
pleted, between 2004 and 2008, a questionnaire on
smoking and other variables and provided urine samples
for determination of UC (ﬁgure 1). The hospital ethics
committee of each centre approved the research protocol,
and all pregnant women gave written informed consent
before inclusion at the ﬁrst trimester of pregnancy.
Information concerning smoking
Questionnaire on tobacco consumption included
smoking history, patterns of consumption (occasional or
regular) and exposure to SHS. We considered the women
who, at this interview, reported smoking occasionally or
daily to be smokers, regardless of their UC levels. Women
who had UC levels higher than the widely used level of
50 ng/ml to distinguish smokers from non-smokers,13–16
but who did not report smoking, were classed as misclassi-
ﬁed. It was considered that the participants were exposed
to SHS when they reported exposure at least twice a week
in any of the following environments: at work, at home or
in leisure time outside the home (eg, bars/restaurants or
other homes). We analysed whether women had any
passive exposure to tobacco smoke (yes or no) and also
the number of exposure sources, between 0 and 3,
Figure 1 Flow chart of the
INfancia y Medio Ambiente birth
cohort in relation to smoking and
urinary cotinine quantification.
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according to the reported places of exposure: at work, at
home and/or elsewhere in leisure time.
Urinary cotinine
The urine samples were collected in the same interview
in the morning during the third trimester of pregnancy.
Urine was collected in 100 ml polyethylene containers
and stored at −20°C. One aliquot of the sample from
each of the participants was sent to the Public Health
Laboratory of Bilbao (Spain) to be analysed. All urine
samples were stored for a minimum of 1 year and a
maximum of 5 years before analysis. The analysis of the
UC was performed by competitive enzyme immunoassay
(EIA) using commercial EIA microplate test kits
(OraSure Technologies, Inc, Bio-Rad) for determining
salivary cotinine adapted for urine samples using urine
controls (0, 2.5, 10 and 50 ng/ml, Bio-Rad). Samples with
UC levels above 50 ng/ml were diluted. Before testing
the urine samples, the method was validated; a certiﬁed
reference material was used (EPA/NIST Reference
Material 8444) to evaluate the repeatability and reprodu-
cibility. The quantiﬁcation limit was 4.0 ng/ml, the coefﬁ-
cient of repeatability 7% and the reproducibility 10%.
Other variables
The women were interviewed twice during pregnancy
(in the ﬁrst and third trimesters of gestation) to obtain
information about their sociodemographic characteris-
tics and lifestyle variables. Social status of the women (or
her partner, if she had never worked outside home) was
deﬁned using Spanish adaptation of the British classiﬁ-
cation system.20
Statistical analysis
The χ2 test was used to test hypotheses for categorical
variables, whereas differences in the distribution of UC,
according to categorical covariates, were evaluated using
the Mann-Whitney U and the Kruskal Wallis tests. In
order to identify the variables independently associated
with being either a smoker, a misclassiﬁed or both, logis-
tic regression models were built including geographical
area and the variables related with the outcome at
p<0.10 in the univariate analysis, and sequentially
excluding those variables not related at p<0.10 in the
adjusted model using the likelihood ratio test. For com-
parability purposes, variables remaining at p<0.10 in any
of the models were entered in all the models. For
ordinal categorical variables, the p for a linear trend was
also calculated.
We used the non-parametric receiver operating charac-
teristic (ROC) curve to analyse the relationship between
the sensitivity (probability of a positive test among
smokers) and false-positive (probability of a positive test
among non-smokers, 1-speciﬁcity) cases for various dif-
ferent cut-off points that dichotomise UC to distinguish
smokers from non-smokers, using self-reported cigarette-
smoking status as the reference value. Overall accuracy
was evaluated by means of the area under the curve
(AUC) (showing the ability of the urinary cotinine to
correctly classify smoking status with varying cut-off
points.21 The optimal cut-off point for UC to discrimin-
ate smokers from non-smokers was the value (c) asso-
ciated with Youden’s index ( J), deﬁned by: J=maximum
{sensitivity(c)+speciﬁcity(c)–1}.22 This value is ‘optimal’
in the sense that it maximises the overall rate of correct
classiﬁcation in the absence of a loss function (ie, giving
the same weight to errors of sensitivity and speciﬁcity).
Since the shape of the distribution of the estimator of
the optimal cut-off point was unknown, we used the per-
centile bootstrap method, with 2000 resampling simula-
tions, to establish 95% CI, with the aid of the ‘boot’
package of R.23 Additionally, the data were analysed for
the most widely used cut-off points, namely 50 and
100 ng/ml, or 25 and 50 ng/ml when analyses were
restricted to occasional smokers. The cut-off points were
also calculated after stratiﬁcation among non-smokers
for SHS exposure in three groups: 798 women that
referred not exposed to SHS, 735 exposed to one source
of SHS and 303 exposed to more than one source.
Additional sensitivity analyses were conducted (see
online supplementary table), the ﬁrst one excluding
1047 pregnant women non-smokers who referred SHS
exposure, the second one excluding 317 self-reported
non-smokers who claimed to have stopped smoking
during pregnancy, since this group is more likely to mis-
report their smoking status, and the last one excluding
35 women who declared that they did not smoke but
had implausible UC levels in non smokers (>500 ng/
ml). Assuming α=0.05, 95% CI were calculated for ORs,
cut-off points and area under the ROC curve. All statis-
tical tests were two-sided. Statistical analysis was carried
out using SPSS (V.17.0) and R (2.11.1) statistical
software.
RESULTS
Study setting and characteristics of the sample
Overall, 61.2% of women reported to have smoked at
least once in their life, whereas 32.4% were occasional
or regular smokers when they became pregnant, falling
to 19.7% at the ﬁrst trimester and 18.5% at the third tri-
mester of their pregnancy (table 1).
Smoking and SHS exposure
The median UC level in women who did not refer to
smoke and were not exposed to SHS was below the quanti-
ﬁcation level of 4.0 ng/ml, whereas in non-smokers
exposed to SHS, it was 7.6 ng/ml. Among all smokers, the
UC median level was 1744.3 ng/ml (table 2). Occasional
smokers had a median level of 260.7 ng/ml. Among daily
smokers, statistically signiﬁcant differences were observed
between UC concentration and the number of cigarettes
smoked per day (p<0.001), showing a clear dose-response
pattern (not statistically tested). In the same way, in non-
smokers, there were statistically signiﬁcant differences
between UC levels and the number of sources of exposure
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to SHS, which are, work, home and elsewhere in leisure
time (p<0.001), with a progressive dose-response pattern
(not tested, neither). Figure 2 shows the different distribu-
tion patterns of UC among non-smokers, exposed or not
to SHS, and occasional and daily smokers.
Self-reported smoking and misclassification
Among the 2263 women studied, 1755 (77.6%) reported
that they did not smoke and had UC levels below 50 ng/ml









≤ 24 154 6.8
25–29 717 31.7
30–34 973 43.0
≥ 35 418 18.5
Social class
I–II (more affluent) 492 21.8
III 584 25.8
IV–V (less affluent) 1186 52.4
Level of education







≥ 30 175 7.7
Previous parity 957 43.1
Birth in Europe 2130 94.3






























≥ 10 91 4.0
Exposed to SHS in non-smoking women†:
Continued
Table 2 Active smoking and exposure to SHS in
pregnant women in the INfancia y Medio Ambiente cohort.
Median levels of urinary cotinine (ng/ml) at the third
trimester of pregnancy
N % Urinary cotinine*
Total 2263 100 7.4
Non-smokers† 1845 81.5 4.4
No SHS exposure 798 35.3 <4
SHS exposure 1038 45.9 7.6
1 source‡,§ 735 32.5 5.8
2 sources 271 12.0 11.7
3 sources 32 1.4 16.9
Smokers§ 418 18.5 1744.3
Occasional 37 1.6 260.7
1–2 cigarettes/day 76 3.4 1036.4
3–4 cigarettes/day 73 3.2 1330.7
5–9 cigarettes/day 141 6.2 1848.5
≥ 10 cigarettes/day 91 4.0 3033.0
SHS, second-hand smoke.
*Median level of urinary cotinine ng/ml.
†Exposed and not exposed to SHS; Mann-Whitney test: p<0.001
for smoking and urinary cotinine.
‡Sources of exposure to SHS at work/at home/in leisure time
outside the home.
§Kruskal Wallis test p<0.001.
Table 1 Continued
N* %
At home (partner or others) 479 26.0
At work 186 10.1
Elsewhere in leisure time‡ 715 38.8





Cotinine (ng/ml) all the women





≥ 1000 318 14.1
*The numbers and rates that do not match the total are due to
missing data.
†Percentages calculated including non-exposed women.
‡Other homes or public places, for example, pubs or restaurants.
§Work, home and elsewhere in leisure time among non-smokers.
BMI, body mass index; SHS, second-hand smoke.
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(true negative). A further 18 (0.8%) also had UC levels
under 50 ng/ml despite claiming to smoke, though 13 of
these claimed to be occasional smokers. On the other
hand, 90 women (3.9%) reported that they did not smoke
but were found to have UC levels above 50 ng/ml and were
considered as misclassiﬁed, and ﬁnally, 400 women
(17.7%) were true positive. Table 3 shows the ORs of the
variables associated with smoking and misclassiﬁcation,
before and after adjusting. In the adjusted model, the risks
of smoking and misclassiﬁcation were associated with low
educational level, country of birth and exposure to SHS.
Age was related only to misclassiﬁcation risk. In regard to
smoking history, only smoking at the beginning of preg-
nancy was associated with misclassiﬁcation. The year of
urine sampling and the social class were statistically asso-
ciated only in the unadjusted analysis. Adding women mis-
classiﬁed to self-reported smokers, the pattern of the
association found with self-reported smoking did not vary.
Cut-off points of UC for smoking
Optimal cut-off points for distinguishing non-smokers
from smokers (daily and occasional), calculated by
Youden’s index, was 82 ng/ml, with a sensitivity of
95.2%, speciﬁcity of 96.6% and AUC of 0.986 (95% CI
0.982 to 0.990) (table 4). Sensitivity and speciﬁcity for
the cut-off points of 50 and 100 ng/ml were quite close
to that of 82 ng/ml. Results of sensitivity analysis are
shown in the online supplementary table. The exclusion
of cases more prone to bias (317 women who declare to
have stopped smoking during pregnancy or 35 self-
reported non-smokers with implausible high UC levels)
did not improve substantially the validation parameters
of the tests.
Youden’s index and AUC for daily smoking were
higher, with a cut-off point of 115 ng/ml. Occasional
smoking was analysed by excluding from the analysis the
381 women who admitted that they smoked regularly at
the third trimester of pregnancy. The optimal cut-off
point for discriminating occasional smokers from non-
smokers was 27 ng/ml (95% CI 11 to 43), with a sensitiv-
ity and speciﬁcity of 89.2% and 89.7%, respectively. The
exclusion of women who declared having quit smoking
during pregnancy improved the speciﬁcity to 91.8%, but
it did not almost change Youden’s index or the sensitiv-
ity. Excluding non-SHS-exposed among non-smokers,
the optimal cut-off point was 19 ng/ml (95% CI 11 to
33), improving the speciﬁcity to 93.7% and the positive
predictive value (probability of smoking status being a
positive test) to 41.2%. Nevertheless, these low positive-
predictive values are a consequence, above all, of the
low prevalence of occasional smoking in this sample.
Women not exposed to SHS compared with all
smokers, daily or occasional, had a lower cut-off point of
42 ng/ml (95% CI 27 to 57), whereas, for those exposed
to one or to two or more sources of SHS, the cut-off
points were 82 (95% CI 55 to 136) and 106 ng/ml (95%
CI 79 to 201), respectively.
DISCUSSION
Main findings in relation to the literature
The prevalence of smoking in pregnant women at the
third trimester was 18.5%. In this later stage, the preva-
lence of active smoking increased up to 22.5%, if
women who did not report smoking but had UC levels
above 50 ng/ml were reclassiﬁed as smokers, assuming
that false-positives were due to maternal misreporting of
smoking status. Prevalence of self-reported smokers and
misclassiﬁed in our study is close to the ones referred by
Kendrick et al6 and Lindqvist et al,7 and the smoking rate
and UC levels are lower than that showed by Pickett
et al.15 Our study had, nevertheless, a lower rate of
smoking misreporting than other studies.2–8
There was a clear relationship between UC and
smoking dose among smokers, and with the number of
sources of exposure to SHS among non-smokers.
Speciﬁcally, those who smoked 10 or more cigarettes per
day had median UC levels of 3033 ng/ml, whereas the
levels were 260 ng/ml for occasional smokers and less
than 17 ng/ml for non-smokers, increasing with the
number of sources of exposure to SHS. These data
reinforce the validity of UC also as an indicator of expos-
ure to SHS.10
England et al13 indicated that few studies have identi-
ﬁed differences between misclassiﬁed and self-reported
smokers and the way in which this would affect epi-
demiological studies. Our study shows similar patterns of
association, and both self-reported smoking and mis-
classiﬁcation were strongly associated with various pre-
dictive variables. In particular, we found a higher risk of
smoking and misclassiﬁcation among women with low
education level. These results are consistent with those
reported by other authors.6 14 24 We also found a higher
risk of smoking and misclassiﬁcation in women from
Europe and women exposed to SHS in different places.
Women younger than 24 years had an increased risk of
Figure 2 Distribution of urinary cotinine (ng/ml) according to
active or passive tobacco exposure in pregnant women from
the INfancia y Medio Ambiente cohort. Me, median; SHS,
second-hand smoking; SRS Occas, self-reported smoking,
occasional; SRS Daily, self reported smoking, daily.
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Table 3 Unadjusted and adjusted ORs and variables associated with smoking






N N OR 95% CI N OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Total 1755 418 – 90 – – – –
Cohort
Asturias 326 75 1 – 15 1 – 1 – 1 – 1 –
Gipuzkoa 467 65 0.60 0.42 to 0.88 13 0.60 0.27 to 1.36 0.77 0.52 to 1.15 0.63 0.28 to 1.42 0.75 0.52 to 1.09
Sabadell 466 99 0.92 0.66 to 1.29 26 1.21 0.61 to 2.44 0.68 0.47 to 0.99 0.81 0.40 to 1.64 0.72 0.51 to 1.02
Valencia 496 179 1.57 1.15 to 2.15 36 1.58 0.82 to 3.07 0.94 0.67 to 1.33 0.84 0.43 to 1.66 0.95 0.69 to 1.31
Age
≤ 24 93 43 1 – 18 1 – 1 – 1 – 1
25–29 537 152 0.62 0.40 to 0.94 28 0.27 0.14 to 0.53 0.87 0.55 to 1.38 0.36 0.18 to 0.73 0.73 0.49 to 1.11
30–34 792 153 0.42 0.27 to 0.64 28 0.18 0.09 to 0.36 0.75 0.48 to 1.19 0.26 0.13 to 0.54 0.61 0.41 to 0.92
≥ 35 332 70 0.46 0.29 to 0.73 16 0.25 0.12 to 0.54 0.90 0.54 to 1.49 0.46 0.21 to 1.04 0.76 0.48 to 1.19
(**p<0.001) (**p = 0.001)
Country of birth
In Europe 1637 410 1 – 83 1 – 1 – 1 1 –
Outside Europe 114 8 0.28 0.13 to 0.60 7 1.21 0.50 to 2.79 0.25 0.12 to 0.54 1.11 0.46 to 2.65 0.39 0.21 to 0.69
Level of education
University 695 59 1 – 22 1 – 1 – 1 – 1 –
Secondary 703 192 3.22 2.36 to 4.39 41 1.84 1.09 to 3.17 2.37 1.70 to 3.29 1.17 0.66 to 2.08 2.08 1.55 to 2.78
Primary or less 355 165 5.47 3.96 to 7.57 27 2.40 1.34 to 4.32 3.30 2.31 to 4.70 1.02 0.53 to 1.97 2.72 1.97 to 3.74
(p**<0.001) (p**=0.002)
Social class
I+II (highest) 438 41 1 – 13 1 – – – –
III 469 96 2.19 1.48 to 3.22 19 1.36 0.67 to 2.80 – – –
IV+V (lowest) 847 281 3.54 2.50 to 5.02 58 2.31 1.25 to 4.26 – – –
(p**<0.001) (p**=0.002)
Year of urine sampling
2004 224 78 1 – 19 1 – – – –
2005 642 179 0.80 0.59 to 1.09 36 0.66 0.37 to 1.18 – – –
2006 362 83 0.66 0.46 to 0.94 21 0.68 0.36 to 1.30 – – –
2007 399 58 0.42 0.29 to 0.61 13 0.38 0.19 to 0.79 – – –
2008 128 20 0.45 0.26 to 0.77 1 0.09 0.01 to 0.70 – – –
(p**<0.001) (p**=0.001)
Exposure to SHS at home
No 1328 144 1 – 34 1 – 1 – 1 – 1 –
Yes 423 274 5.97 4.75 to 7.51 56 5.17 3.33 to 8.03 4.41 3.44 to 5.64 3.26 2.03 to 5.25 4.39 3.49 to 5.51
Exposure to SHS at work
No 1582 343 1 – 76 1 – 1 – 1 1 –





























































N N OR 95% CI N OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Exposure to SHS elsewhere
in leisure time
No 1082 175 1 – 44 1 – 1 – 1 – 1 –
Yes 669 243 2.25 1.81 to 2.79 46 1.69 1.11 to 2.59 1.88 1.44 to 2.34 1.47 0.92 to 2.34 1.80 1.44 to 2.26
Reported having smoked
in their life ††
No 862 0 – 17 1 – – – –
Yes 893 418 – 73 4.15 2.43 to 7.09 – – –
Reported smoking at the start of
pregnancy ††
No 1489 1 – 39 1 – – 1 – –
Yes 266 417 – 51 7.32 4.73 to 11.33 – 6.21 3.91 to 9.86 –
Self-reported and misclassification of smoking status.
*Only variables shown in the table were entered in the logistic equation.
†Non-smokers: women who reported that they did not smoke and were found to have urinary cotinine levels of less than 50 ng/ml in the reference group.
‡Smokers: those who reported smoking.
§Misclassification: those who claimed that they did not smoke but were found to have urinary cotinine levels above 50 ng/ml.
¶Both: c+d.
**p for trend.






















































misreport in their smoking, as indicated by Dietz et al.4
In this study, exposure to SHS was associated with
smoking. In other words, there were more smoking
people around pregnant women who smoked. In add-
ition, misclassiﬁcation was signiﬁcantly associated with
exposure to SHS at home. Jhun et al14 and Orr et al25
also showed higher prevalence of smoking among preg-
nant women whose partners smoked at home. Having
smoked previously was associated with a higher probabil-
ity of misreporting the habit, as observed by England
et al.13
This work showed an optimal cut-off point for discrim-
inating pregnant women smokers from non-smokers of
82 ng/ml, with a CI of 42 to 136 ng/ml. Some studies
proposed a cut-off of 50 ng/ml,13–16 coherent with the
women not SHS exposed in this study. Other studies pro-
posed cut-off points of 79 ng/ml18 and 85 ng/ml,6 closer
to the smoking dose and SHS exposure in our study
sample. In our study population, both the prevalence of
smoking and of SHS is high, and this can explain, in part,
why our optimal cut-off point is higher than those
reported in other studies.13–17 This is also supported by
the fact that the optimal cut-off point decreased to
42 ng/ml (27– 57) when the analysis was restricted to
women who reported no SHS exposure and increased
according to the number of sources reported. The valid-
ity of 27 ng/ml (11– 43) as a cut-off point for differentiat-
ing occasional smokers from non-smokers was lower than
that for differentiating daily smokers, and it could
depend on SHS exposure and on the time spent from
the last cigarette smoked, given the faster elimination of
cotinine in pregnant women,10–12 information not col-
lected in this study. There are no validation studies of
cotinine in different biological matrices, blood (plasma
or serum), saliva or urine,9 16 so it cannot be established
which biomarker is the most reliable.
Limitations of the study
The current study has several limitations. From the eli-
gible population, the participation rate was 56%, and
85.6% of the women who agreed to participate com-
pleted the study. Therefore, the ﬁnal study sample might
not be fully representative of all pregnant women in the
study areas, but its internal validity (absence of bias) is
Table 4 Parameters for assessing the optimal cut-off point for urinary cotinine (ng/ml) obtained by Youden’s index, as well
as the levels of 25, 50 and 100 ng/ml, for classifying pregnant women as regular or occasional smokers
Youden’s index* Cut-off point (95% CI)† Sensitivity Specificity Positive PV‡ Negative PV‡
AUC of the ROC
(95% CI)§
Regular and occasional smokers: 1845 non-smokers, 418 smokers
– 50 0.957 0.951 0.816 0.990
– 100 0.950 0.966 0.865 0.988 0.986 (0.982 to 0.990)
0.918 82 (42 to 136) 0.952 0.966 0.863 0.989
Results stratified by frequency of smoking
Occasional smokers: 1845 non-smokers, 37 smokers
– 25 0.892 0.870 0.121 0.998
– 50 0.649 0.951 0.211 0.993 0.947 (0.923 to 0.970)
0.772 27 (11 to 43) 0.892 0.880 0.130 0.998
Daily smokers: 1845 non-smokers, 381 smokers
– 50 0.987 0.951 0.807 0.997
– 100 0.982 0.966 0.858 0.996 0.990 (0.986 to 0.994)
0.949 115 (57 to 189) 0.982 0.967 0.862 0.996
Results stratified by SHS exposure among non-smokers
Non-exposed to SHS: 798 non-smokers, 418 active smokers
– 50 0.957 0.987 0.976 0.978
– 100 0.950 0.990 0.980 0.974 0.994 (0.990 to 0.998)
0.954 42 (27 to 57) 0.971 0.982 0.967 0.985
Exposed to SHS (1 source**): 735 non-smokers, 418 active smokers
– 50 0.957 0.935 0.893 0.974
– 100 0.950 0.958 0.928 0.971 0.981 (0.974 to 0.989)
0.910 82 (46 to 136) 0.952 0.958 0.928 0.972
Exposed to SHS (2–3 sources**): 303 non-smokers, 418 active smokers
– 50 0.957 0.894 0.926 0.938
– 100 0.950 0.924 0.945 0.930 0.977 (0.966 to 0.987)
0.877 106 (58 to 227) 0.950 0.927 0.947 0.930
*Youden’s index=max (sensitivity+specificity−1).
†95% Bootstrap CI for the cut-off point associated with Youden’s index.
‡Predictive value of a positive or negative result for the prevalence of smoking in the study group.
§Area under the receiver operating characteristic curve and 95% CI.
**Number of sources of exposure at work, home and elsewhere in leisure time.
SHS, second-hand smoking.
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not necessarily affected. There were other likely sources
of misclassiﬁcation in addition to maternal misreporting
of smoking status as misclassiﬁcation of non-smokers as
smokers because of the high degree of exposure to SHS.
On the other hand, women who smoked occasionally
but reported to be non-smokers might have low UC con-
centrations if they had not smoked recently, and their
self-report and UC levels would be in agreement.
No information about last cigarette or last SHS expos-
ure was obtained. We lost the opportunity of analysing
this variable in the evolution of the UC, showing its
inﬂuence in false negatives, above all, and especially
relevant for occasional smokers.
Since the optimal cut-off point for UC is determined
using self-reported smoking status as the gold standard,
the validity of this assumption is important. On the one
hand, it is unlikely that a non-smoking woman declared
to be a smoker because a battery of items should be
completed detailing smoking habits in this case. On the
other hand, however, it is possible that some smokers
did not reveal their habits. In order to minimise this
type of bias, we excluded, in the additional analysis, self-
reported non-smokers with implausibly high UC levels.
In another sensitivity analysis, we excluded self-reported
non-smokers who claimed to stop smoking during preg-
nancy, since these cases are at a higher risk of misclassiﬁ-
cation, as reported in table 3; the optimal cut-off point
did not change after these exclusions. In general terms,
the AUC shows a good overall accuracy, and we think
that self-reported smoking is a reliable measure in this
study. If some kind of misclassiﬁcation occurs, it would
lead to a shift towards the right in both distributions and
a slight overestimation of the optimal cut-off point as a
result.
One of the main strengths of this study was the possi-
bility of assessing the role of baseline exposures to SHS
in the estimate of cut-offs, given the detailed informa-
tion collected on SHS exposure and its elevated preva-
lence. The conﬁrmation that the cut-offs would differ
according to the level of exposure to SHS emphasises
the need of taking it into account, especially in coun-
tries with elevated SHS exposure.
Implications for practice
This study shows that the efforts made to encourage
women to give up smoking before or during pregnancy are
not sufﬁcient or particularly effective, given that at least
18.5% of the pregnant women smoked in the third trimes-
ter. The results of this study indicate that the groups to
which the most effort should be directed are young
women, those of a European origin and those from a low
social class. Further, the association observed in this study
between active smoking of pregnant women and the pres-
ence of smokers in their close environment supports the
hypothesis that this factor makes it more difﬁcult to stop
smoking.26 It is necessary to undertake effective pro-
grammes for reducing smoking before and during
pregnancy, reaching also misclassiﬁed, and to reduce SHS
exposure, in order to prevent risks for women and to the
fetus.
CONCLUSION
Smoking is an important risk factor for health and develop-
ment and should be taken into account as a confounder
when analysing the potential effects of environmental con-
taminants in studies like the INMA project. Having a reli-
able marker like UC and a valid cut-off point that is able to
discriminate regular or occasional smokers from non-
smokers are critical issues. The cut-off point of 82 ng/ml
showed a good validity for discriminating smokers from
non-smokers in our study sample, whereas 27 ng/ml is the
optimal point for discriminating occasional smokers from
non-smokers. It should be emphasised that cut-offs would
differ based on baseline exposure to SHS, and this should
be taken into account when selecting reference cut-offs for
speciﬁc populations.
Author affiliations
1Public Health Department, Basque Government, San Sebastian, Spain
2University of Basque Country UPV/EHU, San Sebastian, Spain
3Health Research Institute (BIODONOSTIA), San Sebastian, Spain
4Spanish Consortium for Research on Epidemiology and Public Health
(CIBERESP), Spain
5Center for Public Health Research (CSISP), Valencia, Spain
6Public Health Agency of Barcelona, Barcelona, Spain
7Institute of Biomedical Research (IIB Sant Pau), Barcelona, Spain
8Public Health Laboratory of Bilbao, Bilbao, Spain
9Center for Research in Environmental Epidemiology (CREAL), Barcelona,
Spain
10Hospital del Mar Research Institute (IMIM), Barcelona, Spain
11Department of Preventive Medicine and Public Health, University of Oviedo,
Oviedo, Spain
12Department of Nursing, University of Valencia, Valencia, Spain
Acknowledgements The authors are grateful to all fieldworkers for their
assistance in administering the questionnaires. A full listing of the INMA
project researchers can be found at http://www.proyectoinma.org/
presentacioninma/listado-investigadores/en_listado-investigadores.html.
Contributors JJA, MM and MR designed the study and analysed the data.
AMC and ME analysed cotinine in urine samples. MJL, AMC, LSM, MG, AF-S,
ME, AL, AT and FB revised the design of the study and the results. JJA wrote
the manuscript and the other authors participated in reviews of the different
drafts and approved the final version.
Funding The INMA project is funded by grants from Instituto de Salud Carlos
III (Red INMA G03/176 and CB06/02/0041) and Fundación Roger Torné. The
studies in the specific regions were funded by the Spanish Ministry of Health
(FIS 03/1615, 04/1436, 04/1509, 04/1112, 04/1931, 05/1079, 05/1052, 06/
0867,06/1213, 07/0314, 08/1151, 09/02647, 04/2018, 09/02311), the
Generalitat de Catalunya (CIRIT 1999SGR00241), the Diputación Foral de
Gipuzkoa (DFG06/004), the Department of Health of the Basque Government
(2005111093), the Regional Government of Andalucía (SAS 07/183), Obra




Ethics approval This study was conducted with the approval for each of the
four cohorts and the hospital ethics committee of each centre.
Provenance and peer review Not commissioned; externally peer reviewed.
Aurrekoetxea JJ, Murcia M, Rebagliato M, et al. BMJ Open 2013;3:e002034. doi:10.1136/bmjopen-2012-002034 9
Smoking and misclassification during pregnancy
group.bmj.com on February 24, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
REFERENCES
1. Murin S, Rafii R, Bilello K. Smoking and smoking cessation in
pregnancy. Clin Chest Med 2011;32:75–91.
2. Bardy AH, Seppälä T, Lillsunde P, et al. Objectively
measured tobacco exposure during pregnancy: neonatal effects
and relation to maternal smoking. Br J Obstet Gynaecol
1993;100:721–6.
3. Burstyn I, Kapur N, Shalapay C, et al. Evaluation of the accuracy of
self-reported smoking in pregnancy when the biomarker level in an
active smoker is uncertain. Nicotine Tob Res 2009;11:670–8.
4. Dietz PM, Homa D, England LJ, et al. Estimates of nondisclosure of
cigarette smoking among pregnant and nonpregnant women of
reproductive age in the United States. Am J Epidemiol
2011;173:355–9.
5. Ford RPK, Tappin DM, Schluter PJ, et al. Smoking during
pregnancy: how reliable are lof maternal self reports in New
Zealand? J Epidemiol Community Health 1997;51:246–51.
6. Kendrick JS, Zahniser SC, Miller N, et al. Integrating smoking
cessation into routine public prenatal care: The
smoking cessation in pregnancy project. Am J Public Health
1995;85:217–22.
7. Lindqvist R, Lendahls L, Tollbom Ö, et al. Smoking during
pregnancy: comparison of self-reports and cotinine levels in 496
women. Acta Obstet Gynecol Scand 2002;81:240–4.
8. Walsh RA, Redman S, Adamson L. The accuracy of
self-report of smoking status in pregnant women. Addict Behav
1996;21:675–9.
9. Gorber SC, Schofield-Hurwitz S, Hardt J, et al. The accuracy of
self-reported smoking: a systematic review of the relationship
between self-reported and cotinine-assessed smoking status.
Nicotine Tob Res 2009;11:12–24.
10. Benowitz NL. Cotinine as a biomarker of environmental tobacco
smoke exposure. Epidemiol Rev 1996;18:188–203.
11. Rebagliato M, Bolúmar F, Florey CV, et al. Variations in cotinine
levels in smokers during and after pregnancy. Am J Obstet Gynecol
1998;178:568–71.
12. Dempsey D, Jacob P, Benowitz NL. Accelerated metabolism of
nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther
2002;301:594–8.
13. England LJ, Grauman A, Qian C, et al. Misclassification of maternal
smoking status and its effects on an epidemiologic study of
pregnancy outcomes. Nicotine Tob Res 2007;9:1005–13.
14. Jhun HJ, Seo HG, Lee DH, et al. Self-reported smoking and urinary
cotinine levels among pregnant women in Korea and factors
associated with smoking during pregnancy. J Korean Med Sci
2010;25:752–7.
15. Pickett KE, Rathouz PJ, Kasza K, et al. Self-reported smoking,
cotinine levels, and patterns of smoking in pregnancy. Paediatr
Perinat Epidemiol 2005;19:368–76.
16. SRNT Subcommittee on Biochemical Verification. Biochemical
verification of tobacco use and cessation. Nicotine Tob Res
2002;4:149–59.
17. Higgins ST, Heil SH, Badger GJ, et al. Biochemical verification of
smoking status in pregnant and recently postpartum women. Exp
Clin Psychopharmacol 2007;15:58–66.
18. Spierto FW, Hannon WH, Kendrick JS, et al. Urinary cotinine levels
in women enrolled in a smoking cessation study during and after
pregnancy. J Smoking Relat Dis 1994;5:65–76.
19. Guxens M, Ballester F, Espada M, et al. Cohort profile: the INMA—
INfancia y Medio Ambiente—(Environment and Childhood) Project.
Int J Epidemiol 2011;41:930–40.
20. Domingo-Salvany A, Regidor E, Alonso J, et al. Proposal for a social
class measure. Working Group of the Spanish Society of
Epidemiology and the Spanish Society of Family and Community
Medicine [Spanish]. Aten Primaria 2000;25:350–63.
21. Zou KH, O’Malley AJ, Mauri L. Receiver-operating characteristic
analysis for evaluating diagnostic tests and predictive models.
Circulation 2007;115:654–7.
22. Perkins NJ, Schisterman EF. The inconsistency of ‘optimal’ cutpoints
obtained using two criteria based on the receiver operating
characteristic curve. Am J Epidemiol 2006;163:670–5.
23. Carpenter J, Bithell J. Bootstrap confidence intervals: when, which,
what? A practical guide for medical statisticians. Stat Med
2000;19:1141–64.
24. Leader A, Fernández-Somoano A, López-Cima MF, et al.
Educational inequalities in quantity, duration and type of tobacco
consumption among lung cancer patients in Asturias:
epidemiological analyses. Psicothema 2010;22:634–40.
25. Orr ST, Newton E, Tarwater PM, et al. Factors associated with
prenatal smoking among black women in eastern North Carolina.
Matern Child Health J 2005;9:245–52.
26. Eiden RD, Molnar DS, Leonard KE, et al. Sources and frequency of
secondhand smoke exposure during pregnancy. Nicotine Tob Res
2011;13:653–60.
10 Aurrekoetxea JJ, Murcia M, Rebagliato M, et al. BMJ Open 2013;3:e002034. doi:10.1136/bmjopen-2012-002034
Smoking and misclassification during pregnancy
group.bmj.com on February 24, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
cotinine: a cross-sectional study
analysis of optimal cut-off points for urinary
misclassification during pregnancy, and 
Determinants of self-reported smoking and
Tardón and Ferran Ballester
Fernández-Somoano, Mercedes Espada, Aitana Lertxundi, Adonina
López, Ane Miren Castilla, Loreto Santa-Marina, Mónica Guxens, Ana 
Juan J Aurrekoetxea, Mario Murcia, Marisa Rebagliato, María José
doi: 10.1136/bmjopen-2012-002034
2013 3: BMJ Open 
 http://bmjopen.bmj.com/content/3/1/e002034






Supplementary material can be found at: 
References
 #BIBLhttp://bmjopen.bmj.com/content/3/1/e002034
This article cites 26 articles, 10 of which you can access for free at: 
Open Access
.http://creativecommons.org/licenses/by-nc/2.0/legalcode
 and http://creativecommons.org/licenses/by-nc/2.0/with the license. See: 
properly cited, the use is non commercial and is otherwise in compliance 
distribution, and reproduction in any medium, provided the original work is
Commons Attribution Non-commercial License, which permits use, 
This is an open-access article distributed under the terms of the Creative
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (108)Smoking and tobacco
 (917)Public health




To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on February 24, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on February 24, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
